FDA Provides EUA for Novacyt’s Covid-19 Diagnostic Test
Novacyt’s covid-19 test produces results in less than 2 hours, and can be used on multiple ubiquitous clinical laboratory instrument platforms.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Novacyt’s covid-19 test produces results in less than 2 hours, and can be used on multiple ubiquitous clinical laboratory instrument platforms.
Read MorePosted by | Apr 2, 2020 | Blood Gas Analyzers, Clinical Chemistry, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Already available in countries requiring the CE mark, the RapidPoint 500e blood gas analyzer is now available for critical care testing in the United States.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Quantitative real-time PCR is proven technology with diagnostic and research applications, including the quantification and genotyping of human pathogens such as SARS-CoV-2.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
Vela Diagnostics will offer the manual ViroKey SARS-CoV-2 RT-PCR test when validation is completed, which is targeted for early April 2020.
Read MorePosted by | Apr 1, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
The kit is a real-time RT-PCR test using samples from oropharyngeal and nasopharyngeal swabs.
Read More